Immunohistochemistry Market Current Scenario 2020 | Size, Share, Trends and Forecast to 2026

According to the current analysis of Reports and Data, The global Immunohistochemistry market was valued at USD 1,736.4 million in 2018 and is expected to reach USD 3,359.8 million by the year 2026, growing at a CAGR of 8.6%. Immunohistochemistry (IHC) has crucial applications in the field of tissue distribution of antigens by using monoclonal and polyclonal antibodies. It is used for cancer diagnosis, because it determines the presence of tumor antigens.

Some of the major Immunohistochemistry market players are Abcam plc; Agilent Technologies; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; Merck KGaA; PerkinElmer, Inc.; and Thermo Fisher Scientific, Inc.

The report includes the latest coverage of the impact of COVID-19 on the Immunohistochemistry industry. The incidence has affected nearly every aspect of the business domain. This study evaluates the current scenario and predicts future outcomes of the pandemic on the global economy.

To Get Sample Copy of Report visit: https://www.reportsanddata.com/sample-enquiry-form/2198

It is a technique which combines immunological, anatomical, and biochemical processes to identify tissue components by the interaction of target antigens with specific antibodies that are tagged by a label. Immunohistochemistry used by public and private organizations to check localization and distribution of cellular components within the cells.

For this report, Reports and Data have segmented the Immunohistochemistry market based on type, disease type, application, end-use, and region:

Type (Revenue, USD Million; 2016–2026)
• Antibodies
o Primary Antibodies
o Secondary Antibodies
• Equipment
o Slide Staining Systems
o Tissue Microarrays
o Tissue Processing Systems
o Slide Scanners
o Others
• Reagents
o Histological Stains
o Blocking Sera and Reagents
o Chromogenic Substrates
o Fixation Reagents
o Stabilizers
o Organic Solvents
o Proteolytic Enzymes
o Diluents
• Kits

Application (Revenue, USD Million; 2016–2026)
• Diagnostics
o Cancer
o Infectious Diseases
o Cardiovascular Diseases
o Autoimmune Diseases
o Diabetes Mellitus
o Nephrological Diseases
• Drug Testing

End Use (Revenue, USD Million; 2016–2026)
• Hospitals and Diagnostic Laboratories
• Clinics
• Research Institutes
• Others

Regional Outlook (Revenue in USD Million; 2016–2026)
• North America
• Europe
• Asia Pacific
• Middle East & Africa (MEA)
• Latin America
• others

Click here to Get customization & check available discount for the report @ https://www.reportsanddata.com/discount-enquiry-form/2198

Immunohistochemistry is being applied in many other areas. Immunohistochemistry is widely used to predict therapeutic response in two important tumors, i.e. carcinoma of breast and prostate. Both these tumors are under the growth regulation of the hormones estrogen and androgen, respectively. The specific receptors for these growth regulating hormones are located on respective tumor cells. Tumors expressing high level of receptor positivity would respond favorably to removal of the endogenous source of such hormones or hormonal therapy is administered to lower their levels – estrogen therapy in prostate cancer and androgen therapy in breast cancer. Immunohistochemistry techniques are also being applied to confirm infectious agent in tissues by use of specific antibodies against microbial DNA or RNA, e.g. in Cytomegalo virus, Hepatitis B virus, Hepatitis C virus, etc.

The application is used routinely in validation of disease targets as it allows visualizing expression of the target in the affected tissue during the disease process. Another important advantage of Immunohistochemistry is that it can also be used to detect organisms in cytological preparations such as fluids, sputum samples, and material obtained from fine needle aspiration procedures. This can be very helpful in certain situations such as detection of pneumocystis from the sputum of an immunocompromised patient who needs rapid and precise confirmation of infection in order to begin immediate and appropriate therapy.

Further key findings from the report suggest

• Immunohistochemistry finds its application in diagnosing cancer types, chronic diseases, neurological diseases and also helps to determine the presence of benign or malignant tumor.
• Immunohistochemistry is more advantageous than traditional enzyme staining techniqueas it involves specific antigen-antibody reactions. It is widely used in clinical diagnostics and medical research laboratories.
• Rapid increase in healthcare spending and a changing healthcare infrastructure with better medical practice and care facilities, rise in geriatric population leads to increased need for Immunohistochemistry techniques are the driving factors of the market
• Antibody segment accounts for largest market share of 41.2% due to rising regulatory approvals for therapeutic antibody products and is expected to show more growth during the forecast period…Continued

Read the Comprehensive Report with a meticulous TOC and panoramic coverage of the market @ https://www.reportsanddata.com/press-release/global-immunohistochemistry-market

In conclusion, the Immunohistochemistry Market report is a reliable source for accessing the Market data that will exponentially accelerate your business. The report provides the principal locale, economic scenarios with the item value, benefit, supply, limit, generation, request, Market development rate, and figure and so on. Besides, the report presents a new task SWOT analysis, speculation attainability investigation, and venture return investigation

Tags: Immunohistochemistry Market, Immunohistochemistry Market Growth, Immunohistochemistry Market Share, immunohistochemistry market size